BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16620579)

  • 1. [Experimental study of T lymphocyte reactivity inhibited by allogeneic bone marrow mesenchymal stem cells].
    Chen JL; Feng K; Guo ZK; U RN; Xu C; Li YH; Liu XD; Mao N; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):740-2. PubMed ID: 16620579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of human bone marrow mesenchymal stem cell on allogeneic T lymphocyte phenotype in vitro].
    Ning HM; Jin JG; Hu JW; Feng K; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):43-9. PubMed ID: 15748434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoregulatory effect of mesenchymal stem cells on active T lymphocytes].
    Ye F; Qiao ZH; Zhu L; Yang T; Yang LH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1116-20. PubMed ID: 18928608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
    Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
    Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of bone marrow mesenchymal stem cells on immunoregulation in H-2 haploidentical bone marrow transplantation mice].
    Hu KX; Zhao SF; Sun QY; Guo M; Ai HS
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):505-9. PubMed ID: 18078123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunoregulatory function of bone marrow mesenchymal stem cells on allogeneic B lymphocytes].
    Liu CT; Yang YJ; Xie M; Wang XL; Yu XH; Wang X; Wang QH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):616-20. PubMed ID: 18246820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune regulatory effect of human bone marrow mesenchymal stem cells on T lymphocyte].
    Lu XX; Liu T; Meng WT; Zhu HL; Xi YM; Liu YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):651-5. PubMed ID: 16129053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation.
    Keyser KA; Beagles KE; Kiem HP
    Cell Transplant; 2007; 16(5):555-62. PubMed ID: 17708345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
    Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
    Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mesenchymal stem cells from human proximal femurs possess immunosuppressive activity].
    Zhang YZ; Fouillard L; Chapel A; Bensidhoum M; Mazurier C; Nasef A; Bouchet S; Lopez M; Thierry D; Gorin NC; Da WM
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2780-4. PubMed ID: 16324321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.
    Bartholomew A; Sturgeon C; Siatskas M; Ferrer K; McIntosh K; Patil S; Hardy W; Devine S; Ucker D; Deans R; Moseley A; Hoffman R
    Exp Hematol; 2002 Jan; 30(1):42-8. PubMed ID: 11823036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sca1(+) mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation.
    Wen F; Zhang HJ; Chen Y; Yue Q; Liu Z; Zhang Q; An N; Chen X; Li N; Xin J; Wang Y; Zhang X; Xu X; Hu X
    Int Immunopharmacol; 2015 May; 26(1):50-7. PubMed ID: 25773667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro.
    Colbath AC; Dow SW; Phillips JN; McIlwraith CW; Goodrich LR
    Stem Cells Dev; 2017 Apr; 26(7):503-511. PubMed ID: 27958776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.